Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer.
Smolska-Ciszewska B, Miszczyk L, Białas B, Fijałkowski M, Plewicki G, Gawkowska-Suwińska M, Giglok M, Behrendt K, Nowicka E, Zajusz A, Suwiński R. Smolska-Ciszewska B, et al. Among authors: nowicka e. Radiat Oncol. 2015 Mar 7;10:60. doi: 10.1186/s13014-015-0366-z. Radiat Oncol. 2015. PMID: 25884489 Free PMC article.
Early closure of phase II prospective study on acute and late tolerance of hypofractionated radiotherapy in low-risk prostate cancer patients.
Behrendt K, Nowicka E, Gawkowska-Suwińska M, Plewicki G, Smolska-Ciszewska B, Giglok M, Suwiński R, Zajusz A. Behrendt K, et al. Among authors: nowicka e. Rep Pract Oncol Radiother. 2014 Jul 15;19(5):337-42. doi: 10.1016/j.rpor.2014.02.006. eCollection 2014 Sep. Rep Pract Oncol Radiother. 2014. PMID: 25184059 Free PMC article.
Tolerability and toxicity of prophylactic cranial irradiation in patients with non-small cell lung cancer - Results of a phase II study (with estimation of hematological toxicity, pituitary function and magnetic resonance spectra changes).
Gawkowska-Suwińska M, Blamek S, Heyda A, Boguszewicz L, Cichoń A, Zarudzki L, Nowicka E, Behrendt K, Smolska-Ciszewska B, Plewicki G, Zajusz A, Tarnawski R. Gawkowska-Suwińska M, et al. Among authors: nowicka e. Rep Pract Oncol Radiother. 2014 Jul 17;19(6):361-8. doi: 10.1016/j.rpor.2014.05.002. eCollection 2014 Nov. Rep Pract Oncol Radiother. 2014. PMID: 25337408 Free PMC article.
Ratio of proliferation markers and HSP90 gene expression as a predictor of pathological complete response in breast cancer neoadjuvant chemotherapy.
Jarzab M, Kowal M, Bal W, Oczko-Wojciechowska M, Rembak-Szynkiewicz J, Kowalska M, Stobiecka E, Chmielik E, Tyszkiewicz T, Kaszuba M, Nowicka E, Lange B, Czarniecka A, Krajewska J, Dyla A, Dobrut M, Lange D, Jarzab B, Bobek-Billewicz B, Tarnawski R. Jarzab M, et al. Among authors: nowicka e. Folia Histochem Cytobiol. 2016;54(4):202-209. doi: 10.5603/FHC.a2016.0026. Epub 2017 Jan 4. Folia Histochem Cytobiol. 2016. PMID: 28051275 Free article.
Safety and Feasibility of Radiation Therapy Combined with CDK 4/6 Inhibitors in the Management of Advanced Breast Cancer.
Kubeczko M, Gabryś D, Gawkowska M, Polakiewicz-Gilowska A, Cortez AJ, Krzywon A, Woźniak G, Latusek T, Leśniak A, Świderska K, Mianowska-Malec M, Łanoszka B, Chomik K, Gajek M, Michalik A, Nowicka E, Tarnawski R, Rutkowski T, Jarząb M. Kubeczko M, et al. Among authors: nowicka e. Cancers (Basel). 2023 Jan 22;15(3):690. doi: 10.3390/cancers15030690. Cancers (Basel). 2023. PMID: 36765648 Free PMC article.
64 results